Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Clinical trial NCT01013285 · COMPLETED
Trial details
- NCT number
- NCT01013285
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2013-10-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.